ArticleHealth science reports2026
Psychobiotics and Mental Health in 2024 Among Romanian Consumers: A Cross-Sectional Survey.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Mental health conditions such as anxiety and depression are prevalent, most notably among vulnerable populations. Psychobiotics are live microorganisms that, when ingested in adequate amounts, may confer mental health benefits via the gut-brain axis. They represent a promising but poorly understood intervention. This study aimed to assess consumer knowledge about psychobiotics and explore the prevalence of anxiety and depressive symptoms, as well as the influence of socio-demographic factors on mental health awareness. Methods: A cross-sectional online survey was conducted among 427 participants, including Romanian residents (87.1%) and Romanians living abroad (12.9%). The questionnaire gathered information on psychobiotic awareness, mental health knowledge, and self-reported symptoms of anxiety and depression over the past 6 months. Statistical analyses were performed to identify associations between socio-demographic factors (age, gender, education, and geographic location) and mental health outcomes. Results: Although 60% of the respondents were familiar with probiotics, only 18.4% reported being very familiar with psychobiotics. This difference was statistically significant ( Conclusions: These findings show limited public awareness of psychobiotics, despite the growing interest in gut and brain health. Targeted public health and educational initiatives are necessary to close this knowledge gap and promote psychobiotics as a potential tool for enhancing mental health. Integrating information about psychobiotics into broader preventive health strategies could improve mental health literacy, foster informed choices, and support early interventions for anxiety and depression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.